Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia

被引：13

作者：

Inamoto, Yoshihiro ^{[1
]}

Flowers, Mary E. D. ^{[2
]}

Wang, Tao ^{[3
,4
]}

Urbano-Ispizua, Alvaro ^{[5
,6
]}

Hemmer, Michael T. ^{[3
]}

Cutler, Corey S. ^{[7
]}

Couriel, Daniel R. ^{[8
]}

Alousi, Amin M. ^{[9
]}

Antin, Joseph H. ^{[7
]}

Gale, Robert Peter ^{[10
]}

Gupta, Vikas ^{[11
]}

Hamilton, Betty K. ^{[12
]}

Kharfan-Dabaja, Mohamed A. ^{[13
]}

Marks, David I. ^{[14
]}

Ringden, Olle T. H. ^{[15
,16
]}

Socie, Gerard ^{[17
]}

Solh, Melhem M. ^{[18
]}

Akpek, Goerguen ^{[19
]}

Cairo, Mitchell S. ^{[20
]}

Chao, Nelson J. ^{[21
]}

Hayashi, Robert J. ^{[22
]}

Nishihori, Taiga ^{[13
]}

Reshef, Ran ^{[23
]}

Saad, Ayman ^{[24
]}

Shah, Ami ^{[25
]}

Teshima, Takanori ^{[26
]}

Tallman, Martin S. ^{[27
]}

Wirk, Baldeep ^{[28
]}

Spellman, Stephen R. ^{[29
]}

Arora, Mukta ^{[30
]}

Martin, Paul J. ^{[2
]}

机构：

[1] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo 1040045, Japan

[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA

[3] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

[4] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53226 USA

[5] Univ Barcelona, Dept Hematol, Hosp Clin, IDIBAPS, Barcelona, Spain

[6] Inst Res Josep Carreras, Barcelona, Spain

[7] Dana Farber Canc Inst, Dept Med Oncol, Ctr Hematol Oncol, Boston, MA 02115 USA

[8] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA

[9] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA

[10] Univ London Imperial Coll Sci Technol & Med, Hematol Res Ctr, Dept Med, Div Expt Med, London, England

[11] Univ Hlth Network, Princess Margaret Canc Ctr, Blood & Marrow Transplant Program, Toronto, ON, Canada

[12] Cleveland Clin, Taussig Canc Inst, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA

[13] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL 33612 USA

[14] Univ Hosp Bristol NHS Trust, Pediat Bone Marrow Transplant, Bristol, Avon, England

[15] Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden

[16] Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden

[17] Hosp St Louis, Dept Hematol, Paris, France

[18] Florida Hosp, Med Grp, Blood & Marrow Transplant Ctr, Orlando, FL USA

[19] Banner MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy Program, Gilbert, AZ USA

[20] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA

[21] Duke Univ, Med Ctr, Dept Med, Div Cell Therapy & Hematol, Durham, NC 27710 USA

[22] Washington Univ, Dept Pediat, Sch Med St Louis, Div Pediat Hematol Oncol, St Louis, MO 63130 USA

[23] Univ Penn, Med Ctr, Abramson Canc Ctr, Dept Med, Philadelphia, PA 19104 USA

[24] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA

[25] Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Div Hematol Oncol, Los Angeles, CA 90024 USA

[26] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan

[27] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA

[28] Seattle Canc Care Alliance, Div Bone Marrow Transplant, Seattle, WA USA

[29] Ctr Int Blood & Marrow Transplant Res, Natl Marrow Donor Program, Be Match, Minneapolis, MN USA

[30] Univ Minnesota, Med Ctr, Dept Med, Div Hematol,Oncol,Transplantat, Minneapolis, MN 55455 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 10期

关键词：

Aplastic anemia; Hematopoietic cell transplantation; Graft-versus-host disease; Immunosuppression; Cyclosporine; Tacrolimus; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; UNRELATED DONOR TRANSPLANTATION; PERIPHERAL-BLOOD; COMPARING METHOTREXATE; SIBLING DONORS; ACUTE GVHD; PHASE-III; GRAFT; PROPHYLAXIS;

D O I：

10.1016/j.bbmt.2015.05.023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Combinations of cyclosporine (CSP) with methotrexate (MTX) have been widely used for immunosuppression after allogeneic transplantation for acquired aplastic anemia. We compared outcomes with tacrolimus (TAC)+MTX versus CSP+MTX after transplantation from HLA-identical siblings (SIB) or unrelated donors (URD) in a retrospective cohort of 949 patients with severe aplastic anemia. Study endpoints included hematopoietic recovery, graft failure, acute graft-versus-host disease (GVHD), chronic GVHD, and mortality. TAC+MTX was used more frequently in older patients and, in recent years, in both SIB and URD groups. In multivariate analysis, TAC+MTX was associated with a lower risk of mortality in URD recipients and with slightly earlier absolute neutrophil count recovery in SIB recipients. Other outcomes did not differ statistically between the 2 regimens. No firm conclusions were reached regarding the relative merits of TAC+MTX versus CSP+MTX after hematopoietic cell transplantation for acquired aplastic anemia, Prospective studies would be needed to determine whether the use of TAC+MTX is associated with lower risk of mortality in URD recipients with acquired aplastic anemia. (C) 2015 American Society for Blood and Marrow Transplantation.

引用

页码：1776 / 1782

页数：7

共 50 条

[1] Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis
Inamoto, Yoshihiro
Martin, Paul J.
Flowers, Mary E.
Urbano-Ispizua, Alvaro
Wang, Tao
Hemmer, Michael T.
Cutler, Corey S.
Couriel, Daniel R.
Alousi, Amin M.
Arora, Mukta
Spellman, Stephen R.
[J]. BLOOD, 2014, 124 (21)
[2] Hematopoietic stem cell transplantation for acquired aplastic anemia
Georges, George E.
Storb, Rainer
[J]. CURRENT OPINION IN HEMATOLOGY, 2016, 23 (06) : 495 - 500
[3] GRAFT FAILURE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACQUIRED APLASTIC ANEMIA
Golubovskaya, I.
Kulagin, A.
Rudakova, T.
Ekushov, K.
Uspenskaya, O.
Bondarenko, S.
Stancheva, N.
Vavilov, V.
Kruchkova, I.
Kozlov, V.
Afanasyev, B.
[J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S440 - S440
[4] Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation
Wirk, Baldeep
[J]. JOURNAL OF HEMATOLOGY, 2024, 13 (03) : 61 - 70
[5] Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia
Miao, Miao
Zhang, Xiang
Xu, Ting
Jin, Song
Wang, Hong
Yang, Xiaofei
Pan, Zhijuan
He, Jun
Sun, Aining
Wu Depei
[J]. BLOOD, 2015, 126 (23)
[6] HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACQUIRED SEVERE APLASTIC ANEMIA
Miao, M.
Zhang, X.
Xu, T.
Jin, S.
Wang, H.
Yang, X.
Pan, Z.
He, J.
Sun, A.
Wu, D.
[J]. HAEMATOLOGICA, 2016, 101 : 629 - 629
[7] Haploidentical hematopoietic stem cell transplantation for acquired severe aplastic anemia
Miao, M.
Zhang, X.
Xu, T.
Jin, S.
Wang, H.
Yang, X.
Pan, Z.
He, J.
Sun, A.
Wu, D.
[J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S353 - S353
[8] Hematopoietic cell transplantation for aplastic anemia
Kumar, Rajat
Bonfim, Carmem
George, Biju
[J]. CURRENT OPINION IN HEMATOLOGY, 2017, 24 (06) : 509 - 514
[9] SWITCH OF CYCLOSPORINE TO TACROLIMUS IN CHILDREN AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Alby-Laurent, F.
Dalle, J. -H.
[J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S308 - S309
[10] Cancers after hematopoietic cell transplantation for aplastic anemia—the importance of persistence
Alicia Rovó
André Tichelli
[J]. Bone Marrow Transplantation, 2022, 57 : 152 - 153

← 1 2 3 4 5 →